Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sam Schulman

Showing results (261-270 of 308) with videos related to

Pageof 31
Sort By:
Chest|February 9, 2012
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesGordon H Guyatt, Susan L Norris, Sam Schulman, et al.
Thrombosis and Haemostasis|July 12, 2012
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery StudySusan R Kahn, Vicky Springmann, Sam Schulman, et al.
Pilot and Feasibility Studies|August 2, 2022
Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trialAnne M Holbrook, Kristina Vidug, Lindsay Yoo, et al.
Journal of Thrombosis and Haemostasis : JTH|July 29, 2022
ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Michelle Sholzberg, Alex C Spyropoulos, et al.
Chest|February 9, 2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn J You, Daniel E Singer, Patricia A Howard, et al.
The New England Journal of Medicine|November 28, 2019
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical ProbabilityClive Kearon, Kerstin de Wit, Sameer Parpia, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2020
Clinical history of cancer-associated splanchnic vein thrombosisEmanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, et al.
Blood Advances|May 25, 2022
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysisMatteo Candeloro, Emanuele Valeriani, Manuel Monreal, et al.
BMJ Open|September 24, 2017
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.
Thrombosis and Haemostasis|March 11, 2008
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situationsAndreas Tiede, R Campbell Tait, Don W Shaffer, et al.
Pageof 31

Showing results (261-270 of 308) with videos related to

Sort By:
Pageof 31
Chest|February 9, 2012
Methodology for the development of antithrombotic therapy and prevention of thrombosis guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesGordon H Guyatt, Susan L Norris, Sam Schulman, et al.
Thrombosis and Haemostasis|July 12, 2012
Management and adherence to VTE treatment guidelines in a national prospective cohort study in the Canadian outpatient setting. The Recovery StudySusan R Kahn, Vicky Springmann, Sam Schulman, et al.
Pilot and Feasibility Studies|August 2, 2022
Coordination of Oral Anticoagulant Care at Hospital Discharge (COACHeD): protocol for a pilot randomised controlled trialAnne M Holbrook, Kristina Vidug, Lindsay Yoo, et al.
Journal of Thrombosis and Haemostasis : JTH|July 29, 2022
ISTH guidelines for antithrombotic treatment in COVID-19Sam Schulman, Michelle Sholzberg, Alex C Spyropoulos, et al.
Chest|February 9, 2012
Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesJohn J You, Daniel E Singer, Patricia A Howard, et al.
The New England Journal of Medicine|November 28, 2019
Diagnosis of Pulmonary Embolism with d-Dimer Adjusted to Clinical ProbabilityClive Kearon, Kerstin de Wit, Sameer Parpia, et al.
Journal of Thrombosis and Haemostasis : JTH|December 11, 2020
Clinical history of cancer-associated splanchnic vein thrombosisEmanuele Valeriani, Marcello Di Nisio, Nicoletta Riva, et al.
Blood Advances|May 25, 2022
Anticoagulant therapy for splanchnic vein thrombosis: an individual patient data meta-analysisMatteo Candeloro, Emanuele Valeriani, Manuel Monreal, et al.
BMJ Open|September 24, 2017
Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysisFaizan Khan, Alvi Rahman, Marc Carrier, et al.
Thrombosis and Haemostasis|March 11, 2008
Antithrombin alfa in hereditary antithrombin deficient patients: A phase 3 study of prophylactic intravenous administration in high risk situationsAndreas Tiede, R Campbell Tait, Don W Shaffer, et al.
Pageof 31